202 related articles for article (PubMed ID: 18313561)
1. Meta-analyses of chronic disease trials with competing causes of death may yield biased odds ratios.
Koller MT; Stijnen T; Steyerberg EW; Lubsen J
J Clin Epidemiol; 2008 Apr; 61(4):365-72. PubMed ID: 18313561
[TBL] [Abstract][Full Text] [Related]
2. A method for the meta-analysis of mutually exclusive binary outcomes.
Trikalinos TA; Olkin I
Stat Med; 2008 Sep; 27(21):4279-300. PubMed ID: 18416445
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
4. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
5. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
Freemantle N; Mason J; Eccles M
Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
7. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.
Pogue J; Walter SD; Yusuf S
Clin Trials; 2009 Jun; 6(3):239-51. PubMed ID: 19528133
[TBL] [Abstract][Full Text] [Related]
10. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
11. Updating meta-analyses leads to larger type I errors than publication bias.
Borm GF; Donders AR
J Clin Epidemiol; 2009 Aug; 62(8):825-830.e10. PubMed ID: 19136233
[TBL] [Abstract][Full Text] [Related]
12. Graphical methods for detecting bias in meta-analysis.
Ferrer RL
Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
[TBL] [Abstract][Full Text] [Related]
13. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
14. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
[TBL] [Abstract][Full Text] [Related]
15. Assessment of risk of bias in randomized clinical trials in surgery.
Gurusamy KS; Gluud C; Nikolova D; Davidson BR
Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
[TBL] [Abstract][Full Text] [Related]
16. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods.
Friedrich JO; Adhikari NK; Beyene J
J Clin Epidemiol; 2011 May; 64(5):556-64. PubMed ID: 21447428
[TBL] [Abstract][Full Text] [Related]
17. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
Olshansky B; Poole JE; Johnson G; Anderson J; Hellkamp AS; Packer D; Mark DB; Lee KL; Bardy GH;
J Am Coll Cardiol; 2008 Apr; 51(13):1277-82. PubMed ID: 18371559
[TBL] [Abstract][Full Text] [Related]
18. A meta-regression analysis shows no impact of design characteristics on outcome in trials on tension-type headaches.
Verhagen AP; de Vet HC; Willemsen S; Stijnen T
J Clin Epidemiol; 2008 Aug; 61(8):813-8. PubMed ID: 18359608
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
Dohoo I; Stryhn H; Sanchez J
Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of repeated measures study designs.
Peters JL; Mengersen KL
J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
